1. Pedersen, S. S., Jensen, T., Pressler, T., Rosendal, K.: Does centralized treatment of cystic fibrosis increase the risk ofPseudomonas aeruginosa infection? Acta Paediatrica Scandinavia 1986, 75: 840–845.
2. Høiby, N., Flensborg, E. W., Beck, B., Friis, B., Vidar-Jacobsen, S., Jacobsen, L.:Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance ofPseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scandinavian Journal of Respiratory Diseases 1977, 58: 65–79.
3. Høiby, N., Friis, B., Jensen, K., Koch, C., Møller, N. E., Støvring, S., Szaff, M.: Antimicrobial chemotherapy in cystic fibrosis patients. Acta Paediatrica Scandinavica 1982, 301, Supplement: 75–100.
4. Cherny, F. J., Cropp, G. J. A., Bye, M. R.: Hospital therapy improves exercise tolerance and lung function in cystic fibrosis. American Journal of Diseases of Children 1984, 133: 261–265.
5. Szaff, M., Høiby, N., Flensborg, E. W.: Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronicPseudomonas aeruginosa infection. Acta Paediatrica Scandinavica 1983, 72: 651–657.